Oriana Capri

Oriana Capri

Auto-generated profile, based on publicly available information

Oriana Capri

Sterility and Assisted Reproduction Unit, Department of Gynecologic‐Obstetrical and Urologic Sciences “Sapienza” University of Rome, Umberto I Hospital Rome Italy

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1992 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
FPFrancesca R. Patacchioli
Francesca R. Patacchioli
GCGiovanni Cigliana
Giovanni Cigliana
ACAntonietta Cilumbriello
Antonietta Cilumbriello
GPGiuseppina Perrone
Giuseppina Perrone
OCOriana Capri
Oriana Capri
LALuciano Angelucci
Luciano Angelucci
In a view of the increased clinical interest in the presence of hormones in human milk, the objective of this study was to evaluate maternal plasma and milk cortisol levels in early puerperium and their relationship in breast-feeding in women who underwent elective cesarean section or who delivered vaginally. During the first 3 days of breast-feeding, plasma and milk cortisol levels declined significantly both in women who underwent elective cesarean section and in women who had spontaneous deliveries. Moreover, the breast-feeding procedure did not affect maternal plasma and milk hormonal levels, since no differences between the cortisol levels measured immediately before and after morning daily breast-feeding were detected. Furthermore, a very high positive correlation (p < 0.001) was found between plasma and milk cortisol concentrations. Therefore, maternal plasma cortisol levels can be considered a very reliable measure to predict the hormonal concentration in breast milk.

1 December 2002 in Maturitas
Verified
Journal Article
Closed access
GPG Perrone
G Perrone
CDC DeAngelis
C DeAngelis
CCC Critelli
C Critelli
OCO Capri
O Capri
PGPaola Galoppi
Paola Galoppi
LZL Zichella
L Zichella

1 July 1999 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
GPG. Perrone
G. Perrone
YLY. Liu
Y. Liu
OCO. Capri
O. Capri
CCC. Critelli
C. Critelli
FBF. Barillaro
F. Barillaro
LZL. Zichella
L. Zichella
The aim of the study was to evaluate the body composition and fat distribution in long-term users of hormonal replacement therapy (HRT). 18 healthy menopausal women, long-term users of HRT (transdermal estradiol 50 μg continuously administered and 10 mg/day of medroxyprogesterone acetate for 12 days/month) and 18 healthy menopausal women, who had never used HRT were included in the study. Age, menopausal age, parity, weight and height (body mass index, weight/height2), and lifestyle habits were similar. Waist and hip circumference, body composition and waist/hip ratio were measured and the results were analyzed. No significant difference was demonstrated in fat and water percentage, and waist/hip ratio. Nevertheless, the waist circumference of long-term HRT users was significantly lower than that of non-users. In conclusion, abdominal fat in long-term HRT users is lower than that of non-users of similar age, menopausal age and body mass index.

1 September 2006 in Maturitas
Verified
Journal Article
Closed access
FPFrancesca Romana Patacchioli
Francesca Romana Patacchioli
SSS. Simeoni
S. Simeoni
PMP. Monnazzi
P. Monnazzi
MPM. Pace
M. Pace
OCO. Capri
O. Capri
GPG. Perrone
G. Perrone

3 October 2013 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
PDF file
RCROSSANA CECCHI
ROSSANA CECCHI
PFPaola Frati
Paola Frati
OCOriana Capri
Oriana Capri
LCLuigi Cipolloni
Luigi Cipolloni

24 May 2013 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
GPGiuseppina Perrone
Giuseppina Perrone
OCOriana Capri
Oriana Capri
PGPaola Galoppi
Paola Galoppi
FPFrancesca R. Patacchioli
Francesca R. Patacchioli
EBElisa Bevilacqua
Elisa Bevilacqua
RBRoberto Brunelli
Roberto Brunelli
Background: Prescriptions for hormone replacement therapy (HRT) declined following the publication of the Women's Health Initiative study. The number of women who experience recurrence of menopausal symptoms after discontinuation of long-term HRT (LT-HRT), the length of time these symptoms last and the preferred alternative treatments remain unknown. Methods: This prospective 3-year follow-up study analyses the prevalence and intensity of menopausal symptoms that occur in young postmenopausal women who discontinued LT-HRT. Symptoms were evaluated using the Menopause Rating Scale. Results: Women (254) who discontinued LT-HRT (mean use: 6.9 ± 2.3 years) were recruited. Mean age at menopause was 48.1 ± 3.4 years. Mean age at discontinuation was 56.8 ± 3.7 years. 23% of the women were lost to follow-up. Of the remaining 196 women, 93% experienced a recurrence of menopausal symptoms within the first year, 25% resumed low-dose HRT, 62% used vaginal estrogens, 54% used phytoestrogens, and 2% used alternative therapies. A decrease in symptom prevalence and intensity was observed during the 3-year follow-up. Conclusions: Symptoms re-appeared in a significant proportion of patients within the first year after discontinuation of LT-HRT. However, after 3 years, the majority of these women were asymptomatic. Patients who discontinue LT-HRT may require a more detailed follow-up immediately after the discontinuation of treatment.